Introduction and Background
Driven Flow™ Technology represents a breakthrough in point-of-care (POC), rapid diagnostic testing. By greatly enhancing the speed, accuracy, and specificity of the canonical lateral Flow assay, the patented Driven Flow™ Technology offers a route to true confirmatory and quantitative POC testing for a multitude of analytes . In combination with ALFA’s benchmark immunochemical fecal occult blood (iFOB) test,1 Driven Flow™ Technology can drastically reduce reaction times, improve accuracy, reduce the sample volume requirements, and increase
confidence in the specificity of this crucial test that prescreens for early detection of colorectal cancer (CRC) or precancerous polyps.
To continue reading, click the image below: